Novo Holdings sets sights on more acquisitions in hot bioindustry sector

Denmarks biggest fund, Novo Holdings, has in a few years built a large portfolio of companies in the biotech industry. More to come, says the man in charge of it all.

Kasim Kutay, CEO at Novo Holdings, sees big opportunities in the bioindustry. | Photo: Kenneth Lysbjerg Koustrup/ERH

The biggest-by-far fund in Denmark is buying green with all of its power, and even more acquisitions could be coming.

The portfolio has been built in just a few years, from almost nothing to now comprising a number of companies spanning everything from bricks made from waste to the future of aviation fuel, in addition to products aiming to push out pesticides for good.

Read the whole article

Get 14 days free access.
No credit card required.

An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP recommends nine new drugs, rejects one

Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.

CEO at WSA: No clarity on EQT exit plans yet

The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.

Further reading

Related articles

Trial banner

Latest news

See all jobs